Given the altered IGFBP3 levels observed in diabetic patients, we interrogated TMEM219 expression in laser-captured islets through RNA sequencing and confirmed it in healthy subjects, patients with T1D, with T2D or at risk for T1D, without any difference among groups (Fig. 2k). Here, TMEM219 is linked to type 2 diabetes mellitus.